Meghmani Organics Ltd (MOL) — shareholding pattern, promoter holding, financials and share price

About Meghmani Organics Ltd (MOL)

Meghmani Organics Ltd operates in the Pesticides & Agrochemicals industry, within the Chemicals sector. It trades on the NSE as MOL and on the BSE under scrip code 543331. Its ISIN is INE0CT101020.

Founded in 1986 as M/s Gujarat Industries, the company was incorporated in 1995 as Meghmani Organics Limited. The company manufactures Pigments and Agrochemicals through its 6 manufacturing facilities located in Gujarat. The company is amongst the top 3 Phthalocyanine based pigment players in the world and amongst the top 10 producers of pesticides in India. [1] Meghmani Organics Ltd (MOL) manufactures green and blue pigment products, which are used to manufacture printing ink, plastic, paints, textiles, leather, and rubber. It also manufactures a wide variety of commonly used pesticides for crop and non-crop applications, this include insect control in wood preservation and food grain storage.

Meghmani Organics Limited is primarily engaged in the production and sale of pigments, agrochemicals, and specialized chemical products with a global footprint in over 75 countries.

The company faced a decline in Q3 FY26 revenue by 13% YoY, mainly due to uncertain US trade policies impacting demand, yet it saw notable growth in its Nano Urea product lineup.

Listed peers in Pesticides & Agrochemicals: India Pesticides Ltd, Astec Lifesciences Ltd, Punjab Chemicals & Crop Protection Ltd, Dharmaj Crop Guard Ltd, Heranba Industries Ltd, Advance Agrolife Ltd.

Valuation & Returns

10 Jul 2026

At ₹47.31 a share on 10 Jul 2026, Meghmani Organics Ltd (MOL) was valued at a price-to-earnings ratio of 41.88x against an industry P/E of 22.12x and a price-to-book of 0.79x on a book value of ₹59.58 per share as of Mar 2025. Solomo computes return on equity of 1.9% and return on capital employed of 6.56% from filed results. Earnings ratios use consolidated results for the twelve months Jun 2025 to Mar 2026.

P/E
41.88x
Industry P/E
22.12x
P/B
0.79x
EPS (TTM)
₹1.13
Book value / share
₹59.58
ROE
1.9%
ROCE
6.56%
ROA
0.93%
Debt / equity
0.55x
Dividend yield
0%
EBITDA margin
12.55%
52-week range
₹36.41 – ₹106.03

Ratios are computed from filed results and the last recorded price. Not investment advice.

Financial Performance

Mar 2026

In the year ended Mar 2026, Meghmani Organics Ltd (MOL) reported revenue of ₹2,174 crore, net profit of ₹29 crore and earnings per share of ₹1.13. That compares with revenue of ₹2,080 crore and net profit of ₹-11 crore in Mar 2025. Figures are consolidated, as filed with the exchanges.

In the quarter ended Mar 2026, revenue was ₹474.34 crore and net profit ₹8.03 crore (consolidated).

Consolidated annual results for Meghmani Organics Ltd (MOL), Mar 2022 to Mar 2026. Revenue and net profit in ₹ crore; EPS in ₹ per share.
MetricMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Revenue (₹ cr)2,4982,5531,5662,0802,174
Net profit (₹ cr)304238-106-1129
EPS (₹)11.979.35-4.17-0.421.13
Compound annual growth for Meghmani Organics Ltd (MOL). Stock price CAGR is price return and excludes dividends.
Measure5Y3Y1Y
Sales growth23.65%-7.03%32.78%
Profit growth-15.77%-40.03%90.00%
Stock price CAGR--18%-54%

Ownership Summary

Jun 2026

As of Jun 2026, promoters hold 48.95% of Meghmani Organics Ltd (MOL) (unchanged from the previous quarter), foreign institutional investors (FII) hold 0.91% and domestic institutional investors (DII) hold 0%. Market capitalisation was ₹1,203 crore on 10 Jul 2026. Shareholding is filed quarterly with BSE and NSE; Solomo carries every filing back to Sep 2021.

Largest disclosed public shareholders in Jun 2026: HUF 2.57%, Gadia Naveen Vishwanath 1.28%. Only stakes above the 1% disclosure threshold are named in filings.

QuarterPromoterPledgedFIIDIIPublic
Jun 202648.95%-0.91%0%51.05%
Mar 202648.95%-1.34%0%51.05%
Dec 202548.98%-1.33%0%51.02%
Sep 202548.98%-1.48%0%51.02%
Jun 202548.98%-1.94%0.37%51.02%
Mar 202549.41%-1.81%0.48%50.59%
Dec 202449.33%-1.89%0.27%50.67%
Sep 202449.33%-2.22%0.42%50.67%
Every quarter since Sep 2021 Filing data, not investment advice.